MKGAF vs ABBV: Which Stock is Better?

Side-by-side comparison of MERCK Kommanditgesellschaft auf Aktien and Abbvie Inc in 2026

Comparison Updated:

MKGAF

MERCK Kommanditgesellschaft auf Aktien

$152.12

ABBV

Abbvie Inc

$214.04

Key Metrics Comparison

MetricMKGAFABBVWinner
Market Cap$66.14B$378.29BABBV
P/E Ratio19.23160.93MKGAF
EPS (TTM)$7.91$1.33MKGAF
Revenue Growth0.0%0.1%ABBV
Gross Margin58.9%71.5%ABBV

Analyze MKGAF

Full quant analysis

Analyze ABBV

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MKGAF or ABBV a better investment?

Comparing MKGAF and ABBV: MERCK Kommanditgesellschaft auf Aktien has a market cap of $66.14B while Abbvie Inc has $378.29B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MKGAF and ABBV?

MKGAF (MERCK Kommanditgesellschaft auf Aktien) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MKGAF or ABBV?

Based on P/E ratios, MKGAF trades at a lower multiple (19.2x vs 160.9x).

Which is growing faster: MKGAF or ABBV?

ABBV has higher revenue growth at 0.1% vs 0.0% for MKGAF.

Which company is more profitable: MKGAF or ABBV?

Abbvie Inc (ABBV) has higher gross margins at 71.5% compared to 58.9% for MKGAF.

Which is the larger company: MKGAF or ABBV?

Abbvie Inc (ABBV) is larger with a market cap of $378.29B compared to $66.14B for MKGAF.

Should I buy MKGAF or ABBV in 2026?

Both MKGAF and ABBV have investment merit. MKGAF trades at $152.12 while ABBV trades at $214.04. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MKGAF and ABBV stock?

Key differences: Market Cap ($66.14B vs $378.29B), P/E Ratio (19.2x vs 160.9x), Revenue Growth (0.0% vs 0.1%), Gross Margin (58.9% vs 71.5%).

Popular Stock Comparisons